What are alternatives to BPC 157?

Alternatives to BPC 157 have emerged, particularly with the increasing unavailability of this peptide. Here are a few noteworthy substitutes discussed by Dr. Craig Koniver MD on the Huberman Lab:

1. Pentadeca Arginate (PDA):

   • Description: PDA is a newer compound that shares a similar molecular structure to BPC 157, differing only by one amino acid substitution (an acetate is swapped for an arginate) 1.
   • Clinical Use: Preliminary results from its use show positive effects, such as reduced inflammation, similar to those reported with BPC 157 1.
   • Dosage: Recommended dosages for PDA range from 250 to 500 micrograms, injected daily for five days a week, followed by two days off 1.

2. Additional Peptides:

   • Research continues into other peptides that might offer similar effects as BPC 157. These include compounds like Thymosin Alpha, Ipamorelin, and TB 500, which are being evaluated for their therapeutic potential 1.

These alternatives highlight ongoing advancements in peptide therapy as alternatives become necessary due to regulatory changes affecting BPC 157's availability. Always consult with a physician before trying new treatments.